Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice

Experimental spinal cord injury (SCI) causes a morphological and functional deterioration of the heart, in which the renin–angiotensin system (RAS) might play a role. The recently discovered non-canonical axis of RAS with angiotensin-(1–7) and its receptor Mas, which is associated with cardioprotect...

Full description

Bibliographic Details
Main Authors: Anne Järve, Fatimunnisa Qadri, Mihail Todiras, Shirley Schmolke, Natalia Alenina, Michael Bader
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2020.00203/full
_version_ 1818854221688078336
author Anne Järve
Anne Järve
Fatimunnisa Qadri
Mihail Todiras
Mihail Todiras
Shirley Schmolke
Natalia Alenina
Natalia Alenina
Michael Bader
Michael Bader
Michael Bader
Michael Bader
author_facet Anne Järve
Anne Järve
Fatimunnisa Qadri
Mihail Todiras
Mihail Todiras
Shirley Schmolke
Natalia Alenina
Natalia Alenina
Michael Bader
Michael Bader
Michael Bader
Michael Bader
author_sort Anne Järve
collection DOAJ
description Experimental spinal cord injury (SCI) causes a morphological and functional deterioration of the heart, in which the renin–angiotensin system (RAS) might play a role. The recently discovered non-canonical axis of RAS with angiotensin-(1–7) and its receptor Mas, which is associated with cardioprotection could be essential to prevent damage to the heart following SCI. We investigated the cardiac consequences of SCI and the role of Mas in female wild-type (WT, n = 22) and mice deficient of Mas (Mas–/–, n = 25) which underwent spinal cord transection at thoracic level T4 (T4-Tx) or sham-operation by echocardiography (0, 7, 21, and 28 days post-SCI), histology and gene expression analysis at 1 or 2 months post-SCI. We found left ventricular mass reduction with preserved ejection fraction (EF) and fractional shortening in WT as well as Mas–/– mice. Cardiac output was reduced in Mas–/– mice, whereas stroke volume (SV) was reduced in WT T4-Tx mice. Echocardiographic indices did not differ between the genotypes. Smaller heart weight (HW) and smaller cardiomyocyte diameter at 1 month post-SCI compared to sham mice was independent of genotype. The muscle-specific E3 ubiquitin ligases Atrogin-1/MAFbx and MuRF1 were upregulated or showed a trend for upregulation in WT mice at 2 months post-SCI, respectively. Angiotensinogen gene expression was upregulated at 1 month post-SCI and angiotensin II receptor type 2 downregulated at 2 month post-SCI in Mas–/– mice. Mas was downregulated post-SCI. Cardiac atrophy following SCI, not exacerbated by lack of Mas, is a physiological reaction as there were no signs of cardiac pathology and dysfunction.
first_indexed 2024-12-19T07:49:16Z
format Article
id doaj.art-f207d01beffb4fbdb5446767bcfccc92
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-19T07:49:16Z
publishDate 2020-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-f207d01beffb4fbdb5446767bcfccc922022-12-21T20:30:15ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2020-03-011110.3389/fphys.2020.00203512398Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in MiceAnne Järve0Anne Järve1Fatimunnisa Qadri2Mihail Todiras3Mihail Todiras4Shirley Schmolke5Natalia Alenina6Natalia Alenina7Michael Bader8Michael Bader9Michael Bader10Michael Bader11Max Delbrück Center for Molecular Medicine, Helmholtz Association of German Research Centers, Berlin, GermanyPartner Site Berlin, German Center for Cardiovascular Research, Berlin, GermanyMax Delbrück Center for Molecular Medicine, Helmholtz Association of German Research Centers, Berlin, GermanyMax Delbrück Center for Molecular Medicine, Helmholtz Association of German Research Centers, Berlin, GermanyNicolae Testemiţanu State University of Medicine and Pharmacy, Chişinãu, MoldovaMax Delbrück Center for Molecular Medicine, Helmholtz Association of German Research Centers, Berlin, GermanyMax Delbrück Center for Molecular Medicine, Helmholtz Association of German Research Centers, Berlin, GermanyPartner Site Berlin, German Center for Cardiovascular Research, Berlin, GermanyMax Delbrück Center for Molecular Medicine, Helmholtz Association of German Research Centers, Berlin, GermanyPartner Site Berlin, German Center for Cardiovascular Research, Berlin, GermanyCharité Universitätsmedizin Berlin, Berlin, GermanyInstitute for Biology, University of Lübeck, Lübeck, GermanyExperimental spinal cord injury (SCI) causes a morphological and functional deterioration of the heart, in which the renin–angiotensin system (RAS) might play a role. The recently discovered non-canonical axis of RAS with angiotensin-(1–7) and its receptor Mas, which is associated with cardioprotection could be essential to prevent damage to the heart following SCI. We investigated the cardiac consequences of SCI and the role of Mas in female wild-type (WT, n = 22) and mice deficient of Mas (Mas–/–, n = 25) which underwent spinal cord transection at thoracic level T4 (T4-Tx) or sham-operation by echocardiography (0, 7, 21, and 28 days post-SCI), histology and gene expression analysis at 1 or 2 months post-SCI. We found left ventricular mass reduction with preserved ejection fraction (EF) and fractional shortening in WT as well as Mas–/– mice. Cardiac output was reduced in Mas–/– mice, whereas stroke volume (SV) was reduced in WT T4-Tx mice. Echocardiographic indices did not differ between the genotypes. Smaller heart weight (HW) and smaller cardiomyocyte diameter at 1 month post-SCI compared to sham mice was independent of genotype. The muscle-specific E3 ubiquitin ligases Atrogin-1/MAFbx and MuRF1 were upregulated or showed a trend for upregulation in WT mice at 2 months post-SCI, respectively. Angiotensinogen gene expression was upregulated at 1 month post-SCI and angiotensin II receptor type 2 downregulated at 2 month post-SCI in Mas–/– mice. Mas was downregulated post-SCI. Cardiac atrophy following SCI, not exacerbated by lack of Mas, is a physiological reaction as there were no signs of cardiac pathology and dysfunction.https://www.frontiersin.org/article/10.3389/fphys.2020.00203/fullrenin–angiotensin systemcardiac atrophyatrogenessympathetic nervous systemfibrosis
spellingShingle Anne Järve
Anne Järve
Fatimunnisa Qadri
Mihail Todiras
Mihail Todiras
Shirley Schmolke
Natalia Alenina
Natalia Alenina
Michael Bader
Michael Bader
Michael Bader
Michael Bader
Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
Frontiers in Physiology
renin–angiotensin system
cardiac atrophy
atrogenes
sympathetic nervous system
fibrosis
title Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
title_full Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
title_fullStr Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
title_full_unstemmed Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
title_short Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
title_sort angiotensin 1 7 receptor mas deficiency does not exacerbate cardiac atrophy following high level spinal cord injury in mice
topic renin–angiotensin system
cardiac atrophy
atrogenes
sympathetic nervous system
fibrosis
url https://www.frontiersin.org/article/10.3389/fphys.2020.00203/full
work_keys_str_mv AT annejarve angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT annejarve angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT fatimunnisaqadri angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT mihailtodiras angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT mihailtodiras angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT shirleyschmolke angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT nataliaalenina angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT nataliaalenina angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT michaelbader angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT michaelbader angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT michaelbader angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice
AT michaelbader angiotensin17receptormasdeficiencydoesnotexacerbatecardiacatrophyfollowinghighlevelspinalcordinjuryinmice